Primary androgen deprivation (PAD) followed by active surveillance for newly diagnosed prostate cancer (PC)

被引:0
|
作者
Scholz, Mark Creamer
Groom, Meg
Kaddis, Andrew
Lam, Richard Y.
Jennrich, Robert
机构
[1] Prostate Oncol Specialists, Marina Del Rey, CA USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
D O I
10.1200/jco.2012.30.5_suppl.244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
244
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Primary androgen deprivation (AD) followed by active surveillance (AS) for newly diagnosed prostate cancer (PC): A retrospective study
    Scholz, Mark C.
    Groom, Meg K.
    Kaddis, Andrew J.
    Strum, Stephen B.
    Jennrich, Robert I.
    Bahn, Duke K.
    Chang, Patricia J.
    Becker, Lauren K.
    Lam, Richard Y.
    PROSTATE, 2013, 73 (01): : 83 - 88
  • [2] Primary Intermittent Androgen Deprivation As Initial Therapy for Men with Newly Diagnosed Prostate Cancer
    Scholz, Mark C.
    Lam, Richard Y.
    Strum, Stephen B.
    LaBarba, Dean J.
    Becker, Lauren K.
    Chang, Patricia
    Farhoumand, Nojan
    Jennrich, Robert I.
    CLINICAL GENITOURINARY CANCER, 2011, 9 (02) : 89 - 94
  • [3] Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer - Discussion
    Sartor, O
    Carroll, PR
    Pollack, A
    D'Amico, AV
    Kantoff, PW
    UROLOGY, 2002, 60 (3A) : 11 - 12
  • [4] Adding Docetaxel to Androgen-Deprivation Therapy in Newly Diagnosed Metastatic Prostate Cancer
    Vogelzang, Nicholas J.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2014, 10 (03) : 10 - 11
  • [5] Isn't Androgen Deprivation Enough? Optimal Treatment for Newly Diagnosed Metastatic Prostate Cancer
    Morgans, Alicia K.
    Beltran, Himisha
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (08) : 818 - +
  • [6] Increased risk of newly diagnosed comorbidities in prostate cancer patients treated with androgen deprivation therapy
    Gallina, Andrea
    Karakiewicz, Pierre I.
    Walz, Jochen
    Jeldres, Claudio
    Trinh, Quoc-Dien
    Traumann, Miriam
    Mc Cormack, Michael
    Perrotte, Paul
    Valiquette, Luc
    Benard, Francois
    Graefen, Markus
    Montorsi, Francesco
    Saad, Fred
    JOURNAL OF UROLOGY, 2007, 177 (04): : 200 - 200
  • [7] Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
    Rusthoven, Chad G.
    Jones, Bernard L.
    Flaig, Thomas W.
    Crawford, E. David
    Koshy, Matthew
    Sher, David J.
    Mahmood, Usama
    Chen, Ronald C.
    Chapin, Brian F.
    Kavanagh, Brian D.
    Pugh, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) : 2835 - +
  • [8] Androgen and prostate cancer: the role of primary androgen deprivation therapy in localized prostate cancer
    Namiki, Mikio
    Kitagawa, Yasuhide
    Mizokami, Atsushi
    Koh, Eitetsu
    JOURNAL OF MENS HEALTH, 2008, 5 (04) : 333 - 341
  • [9] THE EFFECT OF DUAL ELIGIBILITY ON THE QUALITY OF ACTIVE SURVEILLANCE IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER
    Faraj, Kassem
    Dunn, Rodney
    Shahinian, Vahakn
    Hollenbeck, Brent
    Herrel, Lindsey
    JOURNAL OF UROLOGY, 2024, 211 (05): : E266 - E267
  • [10] THE EFFECT OF DUAL ELIGIBILITY ON THE QUALITY OF ACTIVE SURVEILLANCE IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER
    Faraj, Kassem
    Dunn, Rodney L.
    Herrel, Lindsey A.
    Hollenbeck, Brent K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S99 - S99